Scott Magargee is the CEO and co-founder of Springbok Analytics, a Charlottesville, Virginia company that turns ordinary MRI scans into FDA-cleared, AI-built 3D maps of every muscle in the human body. A former Princeton history major and Top 100 law firm litigator, he traded courtrooms for muscle health, joining the University of Virginia spinout in December 2019 and steering it through a $5M oversubscribed Series A in January 2025 backed by the NBA. Under his watch, Springbok has scanned elite athletes, pro basketball leagues, and clinical-trial patients, chasing a single idea: make muscle visible, measurable, and actionable.
PhenoMx, Inc. is a New York digital health company turning ordinary MRI scanners into a 'Personalized Digital Physical Exam.' Its software-first platform applies quantitative imaging and machine learning to non-invasive MRI scans, measuring organs, tissues, body composition, brain, heart and joints over time. Founded in 2017 by Mark Punyanitya and Girish Srinivasan, PhenoMx aims to make precision medicine accessible far beyond the wealthy - from concierge athletes to value-based care and clinical trials worldwide.
Mark Punyanitya is a New York biomedical engineer turned founder who spent more than fifteen years measuring the human body one MRI slice at a time, then set out to make that kind of imaging cheap and portable enough to put in the back of a truck. As Co-Founder, President and CEO of PhenoMx, Inc. and founder of the Image Reading Center, he turns advanced scanning into quantitative imaging biomarkers for global clinical trials and a 'digital physical exam' for precision medicine and longevity. With 44-plus published papers behind him, he is trying to liberate medical imaging from the basements of academic hospitals and disperse it anywhere, anytime.
RapidAI builds FDA-cleared clinical AI software that reads CT, CTA, CT perfusion and MRI scans to flag stroke, aneurysms and pulmonary embolisms in minutes - giving hospital teams a faster path to treatment. The platform began life as the Stanford spin-out iSchemaView and now runs in more than 2,000 hospitals across 100+ countries.
Promaxo builds the world's first single-sided, in-office MRI platform - a compact magnet, AI, and robotics stack that lets urologists run image-guided prostate biopsies and focal treatments in their own clinic, without a hospital scanner suite.
Subtle Medical is a Stanford-born AI company that makes regular MRI and PET scanners faster and sharper through deep learning denoising and image enhancement software. Its FDA-cleared, vendor-neutral products - including SubtlePET, SubtleMR/SubtleHD, SubtleSYNTH and AiMIFY - help radiology departments shorten scan times, reduce contrast dose, and increase patient throughput without buying new hardware.
Enhao Gong is the CEO and co-founder of Subtle Medical, a Stanford-born AI healthcare company that has earned 9 FDA clearances for deep learning-powered medical imaging products. A PhD graduate from Stanford in Electrical Engineering, Gong co-founded Subtle Medical in 2017 alongside Stanford neuroradiologist Dr. Greg Zaharchuk, and has grown the company to serve 1,000+ scanner installations globally, touching 2.5 million patients annually. Before Subtle Medical, he co-founded Polarr, an AI photo-editing startup used by tens of millions. He has been recognized by Forbes 30 Under 30 (China/APAC, 2018), Fortune 40 Under 40, and Radiology Business 40 Under 40 (2024), and led Subtle Medical to TIME's World's Top HealthTech Companies list in 2025.
Dr. Prithipal S. Sethi is a board-certified urologist, founder and CEO of Golden State Urology, and Chief Medical Officer at Promaxo - the company pioneering in-office MRI technology for prostate cancer diagnosis and treatment. With over 25 years of clinical practice, 2,500+ enlarged prostate procedures performed, and a career rooted in bringing advanced imaging technology directly into the urologist's office, Sethi straddles the worlds of clinical medicine and medical device innovation. Trained at UC Berkeley, St. Louis University, and Medical College of Wisconsin, he built Golden State Urology from a single Stockton practice in 2004 into a multi-location Northern California institution, and now serves as a clinical voice for a technology that is reshaping how prostate cancer is caught and treated.